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Abstract
Although the intestinal tract plays a major role in early human immunodeficiency virus (HIV) infection, the role of immune
activation and viral replication in intestinal tissues is not completely understood. Further, increasing evidence suggests the
early leukocyte activation antigen CD69 may be involved in the development or regulation of important T cell subsets, as
well as a major regulatory molecule of immune responses. Using the simian immunodeficiency virus (SIV) rhesus macaque
model, we compared expression of CD69 on T cells from the intestine, spleen, lymph nodes, and blood of normal and SIV-
infected macaques throughout infection. In uninfected macaques, the majority of intestinal lamina propria CD4+ T cells had
a memory (CD95+) phenotype and co-expressed CD69, and essentially all intestinal CCR5+ cells co-expressed CD69. In
contrast, systemic lymphoid tissues had far fewer CD69+ T cells, and many had a naı ¨ve phenotype. Further, marked,
selective depletion of intestinal CD4+CD69+ T cells occurred in early SIV infection, and this depletion persisted throughout
infection. Markedly increased levels of CD8+CD69+ T cells were detected after SIV infection in virtually all tissues, including
the intestine. Further, confocal microscopy demonstrated selective, productive infection of CD3+CD69+ T cells in the
intestine in early infection. Combined, these results indicate CD69+CD4+ T cells are a major early target for viral infection,
and their rapid loss by direct infection may have profound effects on intestinal immune regulation in HIV infected patients.
Citation: Wang X, Xu H, Alvarez X, Pahar B, Moroney-Rasmussen T, et al. (2011) Distinct Expression Patterns of CD69 in Mucosal and Systemic Lymphoid Tissues in
Primary SIV Infection of Rhesus Macaques. PLoS ONE 6(11): e27207. doi:10.1371/journal.pone.0027207
Editor: Zandrea Ambrose, University of Pittsburgh, United States of America
Received July 12, 2011; Accepted October 11, 2011; Published November 9, 2011
Copyright:  2011 Wang et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by National Institutes of Health grants AI49080, AI084793, and RR000164, and a Faculty Enhancement Grant from Tulane
University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: rveazey@tulane.edu
Introduction
It is increasingly clear that the pathogenesis of HIV/SIV
infection and AIDS is closely related to the activation state of the
host immune system, and the immunologic and virologic events
that occur during the earliest stages of infection may have a strong
impact on disease progression [1,2,3,4]. However, the relationship
between the immune activation status of the host, viral replication,
and infection or loss of specific immunoregulatory cells in tissues is
not completely understood. Further, considerable debate exists as
to what molecular markers truly define ‘‘activated’’ versus
‘‘resting’’ cells, particularly in mucosal tissues, and increasing
evidence suggests CD69, previously considered to be an early
activation marker, may also play a major role in immune
regulation [5,6,7].
Several immunophenotypic markers have been used to evaluate
the level of lymphocyte activation, including CD69, HLA-DR,
CD25 (interleukin-2 (IL-2) receptor), CD38, Ki-67, and CD95. Of
these, CD69 has been identified as the earliest activation marker
on the surface of antigen- or allergen-specific activated lympho-
cytes, preceding the appearance of HLA-DR, CD25 and CD71
(transferrin receptor) [8]. Further, CD69 has been shown to be
selectively expressed in chronic inflammatory infiltrates, and at the
sites of active immune responses in vivo [9]. Although the specific
role(s) of CD69 in vivo is not fully known, in vitro studies suggest it
may act as a co-stimulatory molecule for T-cell activation and
proliferation [10]. Moreover, CD69 is rapidly expressed upon T-
cell activation in response to various stimuli, and is readily
amenable to detection by immunofluorescence and flow cytom-
etry, increasing its utility as a rapid response marker in assays of
immune activation [11,12]. Other activation markers are only
upregulated late after activation (CD25, HLA-DR) and/or
associated more with antigen experience (CD95) or cell prolifer-
ation (Ki-67) than activation per se.
Most of our evidence for CD69 as an activation marker comes
from assays based on responses of peripheral blood lymphocytes.
For example, CD69 is considered an early activation marker as it
is rapidly upregulated on essentially all bone marrow derived
lymphocytes following in vitro stimulation [5,13]. However, CD69
is also transiently expressed on developing T lymphocytes in the
thymus [14,15,16] and recent evidence suggests there may be
multiple roles for CD69 expression including immune regulation,
inflammation, trafficking, and possibly even in the development of
anergy or tolerance [5,6,7]. Thus, while CD69 is clearly associated
with early cell activation, its role may differ in various tissues or
cellular microenvironments. Further, more recent evidence
suggests CD69 may directly influence the development of Treg
CD4+ T cells, enhance differentiation of Th17 cells [13], and
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role in regulating immune responses to infections such as SIV/
HIV.
Studies have consistently confirmed that memory CD4+ T cells
are rapidly depleted in tissues of SIV and HIV-infected hosts, and
this depletion is much more profound in the intestine than in
peripheral lymphoid tissues [18,19,20,21,22]. Although it has been
proposed that this rapid and dramatic loss of intestinal CD4+ T
cells is due to the high proportion of ‘‘activated’’ memory CD4+ T
cells expressing CCR5 which are more permissive of viral infection
[23], the mechanisms by which these cells are eliminated remain
controversial. Here we evaluated the expression of CD69 on T cell
subsets from various tissues of normal rhesus macaques, and
assessed dynamic changes in activated T cells throughout SIV
infection.
Results
Distribution of CD69+ CD4+/CD8+ T cells in tissues of
normal rhesus macaques
By flow cytometry, percentages of both CD4+ and CD8+ T cells
co-expressing CD69 were markedly lower in blood compared to
other tissues (Fig. 1) consistent with circulating T cells having a
mostly ‘‘resting’’ phenotype. In contrast, most CD4+ T cells in the
intestine co-expressed CD69 (mean 87%, range 80–95%), and a
large percentage of CD4+ T cells in the mesenteric lymph node
(33%) and spleen (21%) co-expressed CD69. Expression of CD69
on CD8+ T cells showed a similar distribution. Specifically, most
CD8+ cells (86.9%) in the intestine co-expressed CD69, and to a
lesser extent, spleen (mean 21.8%) and mesenteric lymph nodes
(mean 22%). Only 3.6% of blood CD8+ T cells co-expressed
CD69 (Fig. 1). Interestingly, CD69 expression on T cells was
higher in mesenteric lymph nodes (GALT) than in axillary lymph
nodes (systemic lymphoid tissue), but these differences were not
significant (data not shown). Combined, these data indicated that
intestinal sites and their draining tissues (mesenteric LN) have
higher levels of CD69 expression than systemic tissues. In the
blood, percentage of circulating CD8+ T cells co-expressing CD69
was higher than that of CD4+ T cells (P=0.002) despite the
overall low levels of CD69 expression in this tissue. However, there
were no such significant differences between CD69 expression on
CD4 and CD8 T cells in other tissues examined.
Intestinal processing procedures do not artificially
upregulate CD69 expression
Procedures required to prepare single cell suspensions from the
intestine require 2–3 hours to perform due to sequential incubation
with a variety of chemicals and potential antigens including EDTA,
collagenase, and fetal calf serum. Since CD69 is rapidly upregulated
upon antigen or mitogen exposure in vitro, it was conceivable that
these procedures could artificially upregulate CD69 ex vivo. To
address this concern, we processed and treated PBMCs and
lymphocytes from blood, lymph node, and spleen using identical
procedures as used for intestinal cell isolation including serial
incubations in media with EDTA followed by collagenase treatment
exactly as above with rapid shaking at 37 degrees for the same time
intervals. As shown in Fig. 2, there was essentially no increase in
CD69 expression or changes in any other markers on T cells in the
blood, lymph node or spleen after cells were subjected to identical
treatments as intestinal cells. Therefore, the intestinal flow
cytometry data we obtained from examining cell suspensions
prepared from intestinal tissues are indeed representative of the cell
phenotypes observed in situ.
Intestinal CD4+T cells expressing CD69 have a ‘‘memory’’
phenotype
To further characterize and phenotype CD69+ T cells subsets, we
examined the co-expression of CD95 (memory marker) and CCR5
(major co-receptor for HIV/SIV) on CD69+ CD4+ and CD8+ T
cells. Significant differences in levels of co-expression of CD95 and
CCR5 were detected on CD4 and CD8+ T cells between tissues of
normal rhesus macaques. Nearly all CD69+CD4+ T cells in the
intestine lamina propria co-expressed CD95, yet many mesenteric
LN, and even more spleen CD69+CD4+ T cells lacked CD95 co-
expression (Fig. 3A). In addition, CCR5 expression was differentially
expressed on CD69+ T cells in tissues as essentially all intestinal
CD4+ T cells that co-expressed CCR5 also expressed CD69, yet
CCR5 was expressed on both CD69+ a n dC D 6 9 n e gTc e l l si n
mesenteric LN and spleen. In contrast, neither CD95+ nor CCR5+
T cellsinbloodco-expressed CD69.Generally,CD8+ T cells showed
similar patterns for co-expression of CCR5 and CD95 (Fig. 3B).
Combined, these data show that CD69 expression is differentially
expressed on naı ¨ve and memory T cell subsets in tissues, and that the
vast majority of CD4+CD69+ Tc e l l si nt h ei n t e s t i n a ll a m i n ap r o p r i a
have a memory phenotype (CD95+). Further, these data confirm that
the vast majority of these activated CD4+ T cells in the intestine are
memory and many co-express CCR5, and are thus optimal target
cells for HIV infection and replication.
Examining CD69 expression in tissues (in situ)
To visualize CD69 positive cells in tissues, and determine if such
activated T cells are the initial targets for SIV infection, we
attempted immunohistochemistry and immunofluoresence for
CD69 on formalin-fixed, paraffin embedded tissue sections
following routine protocols. However, in contrast to the flow
cytometry data, very few CD69+ cells were detected in formalin-
fixed tissues (best staining is represented in Fig. 4A and C). Since
formalin can cross-link proteins/antigens of interest, we attempted
several different antigen retrieval methods that we have used
successfully, including high-pressure steam, pressure cooking,
proteinase K treatment, and high pH unmasking buffer treatment,
none of which improved the detection of CD69 on formalin fixed
tissues (data not shown). Thus, we hypothesized that formalin
fixation irretrievably cross-linked CD69 expression in tissues, and
thus resorted to snap frozen tissues for immunofluoresence and
confocal microscopy analysis of CD69 expression in situ.
Figure 1. Expression of CD69 on CD4+ and CD8+ T cell in
tissues of normal (non-infected) adult rhesus macaques. Note
the intestine has far more CD69+ T cells than other peripheral lymphoid
tissues, and T cells in blood lack CD69 expression. Bars represent mean
percentages of CD69+ cells when gating through either CD3+CD4+
(black) or CD3+CD8+ (white) T cell subsets 6 SEM. Significant
differences between CD4 and CD8 are indicated by asterisks as;
**P,0.01 using a Mann Whitney U test.
doi:10.1371/journal.pone.0027207.g001
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from adjacent blocks of snap-frozen tissue from the same animal,
we found markedly higher CD69 expression on frozen sections
(Fig. 4B and D) than on formalin fixed tissues (Fig. 4A and C).
Further, CD69+ cells co-expressed either CD4 or CD8, and CD3
(Fig. 5A, B, C and D), consistent with the flow cytometry data on
cell suspensions from the same animals. Combined, these findings
demonstrated that detection of CD69 on formalin fixed, paraffin
embedded tissues is problematic and that frozen sections must be
used to evaluate CD69 expression in situ.
Using three color immunofluorescence and confocal microsco-
py, we simultaneously examined P28 antigen (SIV gag), CD69 and
CD3 expression on frozen tissues from 3 early SIV infected
macaques (8 d.p.i.), and found that most SIV-infected T cells
(P28+CD3+) in both mesenteric lymph node (mean 62%) and
jejunum (mean 80%) also co-expressed CD69 (Fig. 5E and F),
verifying that CD69+ T cells were indeed major initial targets for
SIV infection in vivo. Further, at least 70% of the SIV+ cells co-
expressed CD3 but it was not determined whether the few CD3
negative SIV+ cells represented macrophages, dendritic cells, or
even T cells that had down regulated CD3.
Dynamics of CD69+ CD4+ and CD69+CD8+ T cells in vivo
during acute SIV infection
To evaluate the effects of SIV infection on activated T cells in vivo,
we also compared levels of CD69+ expression on T lymphocytes
from the blood, spleen, mesenteric LN and intestine of animals at
various stages of SIV infection. We found SIV infection had
profound effects on both activated CD4 and CD8 T cells. As shown
in Fig. 6, SIV infection resulted in significantly increased levels of
CD69+CD8+ T cells in all tissues examined, including blood
(P=0.0072), spleen (P,0.0001), mesenteric lymph node (P,0.0001)
and jejunum (P,0.0001). In blood, there was a transient yet
significant (P,0.0001) increase in percentages (Fig. 6A)a n d
absolute numbers (Fig. 6B)o fC D 6 9 +CD4+ T cells at 10 days of
infection, but this subsequently declined. Marked declines in
CD4+CD69+ T cells were observed in jejunum (P,0.0001) and
mesenteric lymph node (P=0.002) by 13 days of infection and
declined thereafter throughout infection. No significant differences
in CD69+CD4+ T cells were detected in spleen (P=0.29) between
uninfected and SIV-infected macaques. Combined, these results
indicate that there are markedly different responses between CD4+
and CD8+ T cells expressing CD69 in tissues; CD8+CD69+ cells
generally increase, whereas CD4+CD69+ cells are rapidly and
persistently depleted in tissues, particularly in GALT.
Although circulating T cells lack CD69 expression in normal
macaques, both CD4+ and CD8+ T cells expressing CD69
increased in blood 10 days after SIV-infection. These CD69+ T
cells mostly co-expressed CD95 (data not shown) indicating these
were cells that had previously encountered antigens and were
currently activated. These cells likely support direct SIV infection
and may play a role in trafficking and dissemination of infected
cells through the blood to tissues in very early infection.
Correlation between viremia and T-cell activation
SIVmac251 infected macaques
As previously reported [5,20,24] we found that peak viral loads
of 10
7 to 10
8 SIV RNA copies/ml were detected in plasma around
Figure 2. Flow cytometry plots showing CD69 and CD25 expression on lymphocytes from peripheral lymphoid tissues immediately
ex vivo (left) and after treatment using the same EDTA/collagenase digestion procedures used to extract intestinal lymphocytes.
Note that these procedures do not artificially up-regulate either activation markers on CD4+ T lymphocytes. Plots were generated by gating on CD3+
lymphocytes, and then CD4+ T cells. Data are representative of tissues from 5 animals performed in 3 separate experiments.
doi:10.1371/journal.pone.0027207.g002
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onset of AIDS (data not shown). Further, plasma viral loads
throughout SIV infection paralleled the levels of CD69+CD4+ T
cells in examined tissues, especially in the intestine (Spearman
r=0.4, P=0.01), and to a lesser extent, in blood (Spearman
r=0.3, P=0.046) and spleen (Spearman r=0.3, P=0.041),
suggesting levels of activated CD4 T cells closely correlate with
plasma viremia. Moreover, gating through the remaining T cells
revealed that the most profound changes in CD69 expression on T
cell subsets were found in blood. As shown in Fig. 7, increased
levels of CD69+ T cells were detected at 8 d.p.i. which peaked at
10 d.p.i., then declined after 13 d.p.i., but were still sustained at
high levels through primary infection. This suggests persistent
immune activation in SIV infection is associated with progression
to AIDS. Similar to activated (CD69+) CD4+ T cells, a positive
correlation was found between plasma VL and CD8+CD69+ cells
in blood (Spearman r=0.35, P=0.03). However, changes in
CD69 expression on T cells in other tissues differed, especially in
intestine. Specifically, despite large numbers of CD69+CD8+ T
cells persisting in the intestine throughout SIV infection,
percentages of remaining intestinal CD4 T cells expressing
CD69 rapidly and continuously declined after 13 days of SIV
infection (Fig. 7) again reflecting differential effects of SIV
infection on CD4+ and CD8+ T cells. Further, a negative
correlation was detected between activated CD8+ T cells and
plasma VLs in both the jejunum (Spearman r=20.4, P=0.01)
and mesenteric lymph nodes (Spearman r=20.4, P=0.02)
suggesting mucosal or GALT CD8+ T cell activation correlates
with control of plasma viremia.
Discussion
Both HIV and SIV cause rapid, persistent depletion of memory
CD4+ T-cells soon after infection, suggesting early immunologic
effects of infection may play a critical role in determining the
subsequent disease. These and prior results have suggested rapid
Figure 3. Phenotyping activated (CD69+) T cells using CD95 (memory marker) and CCR5 (HIV/SIV co-receptor) expression on CD4
or CD8+ T cell subsets from various tissues of normal rhesus macaques. Note the vast majority of the memory CD95+CD4+ (A) and
CD95+CD8+ (B) T cells in the intestine co-express CD69+, while far fewer memory cells co-express CD69 in other tissues. Also note CCR5 expression is
limited to CD69+ T cells in the jejunum, but expressed on both CD69+ and CD69 negative cells in other tissues. Plots were generated by gating
through CD3+ lymphocytes and then CD4+ or CD8+ T cells.
doi:10.1371/journal.pone.0027207.g003
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combination of their state of activation and expression of high levels
of CCR5 [20,25,26]. We originally proposed that cell activation,
particularly in tissues plays a major role in viral replication,
amplification, and systemic spread of infection through such
activated cells [25,27]. More recently, mucosal (gut) damage has
also been shown to promote systemic immune activation fueling
HIV-1 persistence and replication in systemic tissues as well [4,28].
Thus, examining levels of immune activation in situ (tissues) is of
critical importance for understanding these early events. However,
markers of immune activation, and assessing levels of immune
activation in vivo is controversial and sometimes problematic due to
both cellular and viral dynamics and the technical limitations of
tracking individual cells in vivo [29]. Moreover, emerging evidence
indicating CD69 is a major immunoregulatory molecule involved in
Treg and Th-17 cell development and regulation [13] merited
further analysis of the dynamics of CD69 expression in early SIV
infection. Examining the distribution and dynamics of CD69
expression in tissues, particularly in early SIV/HIV infection may
provide important clues to the immune dysregulation that is
associated with progression to AIDS.
Of known activation markers, CD69 has been shown to be the
earliest marker for T cell activation. It is expressed by T cells
within 30 min of T-cell receptor ligation, and is readily amenable
to detection by immunofluorescence and flow cytometry
[11,12,30]. Flow cytometry data revealed levels of CD69
expression markedly differed on T cells isolated from different
tissue sites in uninfected macaques (Figs. 1 and 3). Further, both
flow cytometry and immunohistochemistry (on frozen tissues) were
concordant, demonstrating that intestinal lamina propria T cells
are overwhelmingly CD69+. The co-expression of CD95 on all,
and CCR5 on most CD69+ T cells in the gut suggests that these
are activated memory T cells, rather than resting or naı ¨ve T cells.
These data are consistent with the hypothesis that intestinal lamina
propria T cells have increased states of activation, which may be
the result of their continuous exposure to foreign antigens from the
intestinal lumen. In other tissues however, many CD69+ cells did
not co-express CD95 or CCR5, suggesting that differential
regulation of CD69 expression may exist in different tissue sites.
Circulating CD4+ T cells in the blood of normal macaques had
minimal CD69 expression, yet substantial percentages of activated
CD69+ T cells were detected in other lymphoid tissues (spleen and
mesenteric lymph node). However, the latter tissues displayed very
different patterns of CD95 and CCR5 expression on CD69+ T
cell subsets. Conceivably, CD69 is only transiently expressed in
peripheral tissues in response to early activation, and may be lost
on cells once they migrate into the blood for recirculation and
trafficking. Alternatively, CD69+ cells may reflect acutely
activated cells that have not had time to convert to a memory
phenotype. Regardless these data demonstrate that virtually all
jejunum lamina propria CD4+ T cells are antigen-experienced
memory cells (CD95+) and co-express CD69, suggesting they are
still in an activated state. Conceivably however, CD69 in intestinal
tissues may be associated with local immune regulation rather than
early ‘‘activation’’, since very few CD69 negative cells could be
detected in this tissue.
Figure 4. Comparison of immunohistochemistry results on formalin fixed (left) and tissues. Figures A and C show CD69 expression in
formalin-fixed, paraffin-embedded intestinal tissues and B and C are snap frozen intestinal tissue sections from adjacent regions of tissue from the
same animal. Note that markedly higher numbers of CD69+ cells are detected when using frozen tissues.
doi:10.1371/journal.pone.0027207.g004
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infection in most tissues examined, consistent with SIV infection
inducing immune activation. However, we found markedly
decreased levels of CD4+CD69+ T cells in the intestine and
mesenteric LN of infected macaques, whereas markedly increased
levels of CD8+CD69+ cells were detected in the same tissues.
This differential response is strongly suggestive of a direct effect of
SIV infection of CD4+ T cells rather than non-specific immune
activation or bystander apoptosis, since activated CD8+ T cells
are actually increased throughout infection (Figs. 6, 7).
Furthermore, phenotyping SIV infected cells in situ demonstrated
marked and selective infection of CD69+ T cells in tissues, which
is also consistent with direct infection of CD4+ T cells (Figs. 5E
and F). Combined, these findings provide additional evidence
that intestinal CD4+ T cells are highly susceptible targets for viral
infection and lysis in early infection, and that activated CD4+ T
cells are selectively depleted in primary infection. The dynamics
of CD4+ T cell destruction and turnover in vivo, particularly in
tissues, make it very difficult to definitively prove the mechanisms
of CD4+ T cell destruction when examining ‘‘snapshots’’ of data
collected at single timepoints [29]. However, the fact that
CD3+CD69+ cells are infected at greater rates than
CD3+CD69neg T cells throughout infection (Fig. 5), combined
with the fact that CD8+CD69+ cells increase and CD4+CD69+
T cells decrease in most tissues (Fig. 6) strongly suggest that
CD69+CD4+ T cells are lost through direct infection and lysis,
rather than ‘‘bystander’’ apoptosis or chronic immune activation
of uninfected cells. If activation-induced bystander apoptosis were
involved, it would seem that CD8+ T cells would also be lost
because they demonstrate even higher levels of activation
(CD69+) than the residual CD4+ T cells, yet both proportions
and numbers of activated CD8+CD69+ T cells show a sustained
increase after SIV infection in all tissues, particularly in intestinal
tissues (Fig. 6). Thus, we believe these data provide solid
evidence that infected, activated CD4+ T cells are being
destroyed, yet the actual mechanism of this loss (apoptosis versus
Figure 5. Phenotyping activated T cells in lymph node (left) and intestine (right) by multilabel immunofluoresence and confocal
microscopy. Note that essentially all intestinal CD4+ (B) and CD8+ (D) T cells co-express CD69 (yellow/white), as most easily observed in images
from individual channels on the left of each figure. Note there are no single positive ‘‘red’’ CD4+CD69neg cells in the intestine (B, D) but some are
present in the lymph nodes (A, C) of . uninfected macaques. Panels E and F show productively SIV-infected cells as indicated by SIV p28 staining (red)
and demonstrate most SIV-infected cells in tissues co-express CD3 and CD69 (purple) in both lymph node (E) and intestine (F) in early SIV infection. A
single large ‘‘pure red’’ SIV+ cell not expressing CD69 or CD3 is visible in the upper left quadrant of E which may be a dendritic cell or macrophage.
This macaque was examined 10 days after SIV infection.
doi:10.1371/journal.pone.0027207.g005
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nism of CD4+ T cell depletion remains a central unresolved issue
in AIDS research [31].
There is abundant circumstantial and in vitro evidence, yet a
limited amount of direct experimental evidence, that immune
activation drives HIV replication in vivo. Further, it is still unclear
Figure 6. Changes in CD69 expressing CD4+ (solid lines) and CD8+ (dotted lines) T cells in various tissues after SIV infection
expressed as (A) percentages of total T cells gated through CD3+ lymphocytes in tissues and (B) absolute counts of CD69+CD4+
and CD69+CD8+ T cells in blood. Note that levels of CD69+CD8+ T cells are increased in all tissues examined. In blood, CD4+CD69+ T cells are
transiently increased at day 10, but rapidly decline to undetectable levels thereafter. In contrast, CD4+CD69+ T cells are rapidly, markedly, and
persistently depleted in the intestine and to a lesser extent in the mes LN (bottom). Moreover, sustained increases in absolute counts of CD69+CD8+
T cells were found in the blood (6A), suggesting the increase in the percentage CD69+ CD8+ T cells showing in Fig. 6A is not due to the proportional
loss of CD69+CD4+ cells in the CD3 gated populations. Combined, these data indicate CD4+CD69+ T cells are rapidly destroyed, whereas CD8+CD69+
T cells rapidly increase in SIV infection. This rapid, profound, and selective loss of intestinal CD69+CD4+ T cells is likely the result of direct viral
infection as evidenced in Fig. 5. Data in A represent mean percentages of T cells gated first through CD3+ T lymphocytes (mean 6SEM).
doi:10.1371/journal.pone.0027207.g006
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both) of viral replication in infected hosts, particularly since most
of the activation is nonspecific for HIV/SIV antigens. Unfortu-
nately, use of CD69 as an activation marker alone may not fully
characterize the status of immune activation. In the intestine,
CD69 appears to be constitutively expressed on CD4+ and CD8+
T cells, since few to no CD69 negative cells were detected in the
lamina propria of the jejunum. This was further supported by the
co-expression of CD95 on virtually all CD69+ cells in the intestine.
Interestingly however, cells in other tissues did not reflect such
concordant expression of CD95 and CD69 expression, suggesting
different functions or regulation of CD69 expression in different
tissue sites.
Although the expression of CD69 has been well documented in
systemic cells (PBMC) the true function of CD69 and/or these
‘‘activated’’ T cells in the intestine remains uncertain, as increasing
evidence shows multiple roles for CD69 as a potential immune
regulator, possibly by, suppressing or dampening immune
responses [17,32] or even regulating the differentiation or
production of key T cell subsets such as Th-17 and CD4+ Treg
cells [13]. It is tempting to speculate that CD69+ cells in the
intestine may be playing a role in the ‘‘oral tolerance’’ of the gut, a
feature thought to be important in suppressing immune responses
to ‘‘food’’ antigens. Further, ‘‘activated’’ T cells in the gut may
simply have higher rates of turnover than those in circulation, and
our data may reflect large percentages of newly arrived T cells that
will soon be replaced by other activated T cells. Although we could
not determine if these cells are being rapidly replaced or had
suppressive functions, our combined data suggest that these are
indeed antigen activated memory cells and are major targets for
early SIV infection, and likely, subject to direct viral-mediated
lysis.
Further, the observation that peak levels of CD69+ expression
occur on both CD4+ and CD8+ T cells in the blood at 10 days
post infection suggest primary SIV infection induces rapid
systemic immune activation in response to infection, and thus
provides even more activated CD4+ T cells, which HIV may use
for additional infection, dissemination, and spread to other tissue
sites in primary infection. Clearly, more studies are needed to
validate these findings in HIV infected patients, but these results
suggest that CD69 expression may play a major role in the early
pathogenesis of HIV infection, and particularly in the rapid
depletion of memory CD4+ T cells in tissues. Early infection and
destruction of intestinal CD4+ T cells appears to be selective for
memory CD4+ T cells co-expressing CD69, which are likely much
more susceptible to infection through expression of appropriate
co-receptors (CCR5) and their increased state of activation.
Nonetheless, since emerging evidence indicates CD69 is a major
Figure 7. Changes in CD69 expression on individual CD4+ (solid lines) and CD8+ (dotted lines) T cell subsets from various tissues in
SIV uninfected and infected macaques. Note that percentages of CD4+ T cells co-expressing CD69 spiked at day 10 post infection in all tissues
and subsequently declined, until the onset of symptoms, when levels again started to rise (compare these to viral load data in Fig. 7). In contrast,
CD4+CD69+ T cells in the jejunum declined after peak viremia. Data represent total mean percentages of CD69+ cells when gating through either
CD3+CD4+ (black) or CD3+CD8+ (white) T lymphocytes (mean 6SEM).
doi:10.1371/journal.pone.0027207.g007
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loss of CD4+ T cells expressing CD69 may have profound
consequences for local immune regulation in specific tissues.
Methods
Ethics Statement
The Institutional Animal Care and Use Committee (IACUC) of
Tulane University approved all macaque procedures described
(protocol permit number 3562). This study was carried out in strict
accordance with the recommendations in the Guide for the Care
and Use of Laboratory Animals of the National Institutes of
Health (NIH) and with the recommendations of the Weatherall
report; ‘‘The use of non-human primates in research’’. All
procedures were performed under anesthesia using ketamine,
and all efforts were made to minimize stress, improve housing
conditions, and to provide enrichment opportunities (e.g., objects
to manipulate in cage, varied food supplements, foraging and task-
oriented feeding methods, interaction with caregivers and research
staff).
Animals and virus
Rhesus macaques (Macaca mulatta) were obtained from and
housed at the Tulane National Primate Research Center. Eight
uninfected rhesus macaques were euthanized for tissue collection
as controls, and another 37 were infected with SIVmac251 or
SIVmac239 and euthanized for tissue collection at various time
points, including very early (acute) at 8 days (n=6), 10 days (n=3),
13 days (n=5) and 21 days (n=4) post infection, or in chronic
infection (defined here as infected over 42 days) with either no
overt signs of disease (chronic asymptomatic, n=6), or with illness
that could not be definitively attributed to AIDS (e.g., nonrespon-
sive diarrhea or weight loss; n=6), and 7 animals with overt signs
of AIDS, all of which had AIDS defining lesions and/or
opportunistic infections including Pneumocystis carinii pneumonia
(n=4), disseminated Mycobacterium avium infection (n=2) or SIV
encephalitis (n=1).
All animals examined in acute infection (21 days or less) were
intravenously infected with 100 TCID50 SIVmac251 to reduce
variation that can occur with mucosal inoculations, but macaques
in chronic infection were either intravenously or intravaginally
inoculated and grouped together irrespective of route of
inoculation.
Cell isolation and flow cytometry
Tissues for flow cytometry and immunohistochemistry were
collected from the jejunum, spleen, mesenteric and axillary lymph
nodes within minutes of necropsy and transported to the lab on ice
for immediate processing. Lymphocytes from the intestine were
isolated and stained for flow cytometry as previously described
[19]. Briefly, intestinal pieces were subjected to serial incubations
with EDTA to remove the epithelium, followed by digestion with
collagenase to extract lamina propria lymphocytes. Peripheral
blood and spleen cells were stained using a whole blood lysis
technique. Blood, spleen, lymph node, and intestinal lymphocytes
from all 45 animals were examined by four color flow cytometry
with fluorescently conjugated monoclonal antibodies to CD4-APC
(L200), CD8-PerCP (SK1), CD25-FITC (M-A251) or CD3-FITC
(SP34-2) combined with CCR5-PE (3A9) or CD69-PE (FN50, BD
Biosciences) in separate tubes. Samples were acquired on a FACS
Calibur flow cytometer (Becton Dickinson) and analyzed with
Flowjo software (Tree star, Inc.). To further characterize CD69+
CD4+ or CD8+ cells in blood and tissues, nine-color flow
cytometry using appropriately diluted, directly conjugated mono-
clonal antibodies to CD45RA-FITC (5H9), CCR5-PE, CD95-PE-
Cy5 (DX2), CD25-PE-Cy7, CD28-APC (28.2), CD69-APC-Cy7,
CD3-Pacific Blue (BD Biosciences) CD8-PE-TR (3B5, Caltag
Laboratories), and CD4-Qdot655 (L200, NIH) was performed on
the same tissues from 5 normal macaques. These samples were
resuspended with BD Stabilizing Fixative (BD Biosciences) and
acquired on an LSRII flow cytometer (Becton Dickinson). Data
were analyzed with Flowjo software (Tree star, Inc.).
Immunohistochemistry and confocal microscopy
Three color immunofluorescent staining for CD69, CD4 or
CD8 and CD3 (T cells) was performed on formalin-fixed, paraffin-
embedded tissues from selected animals (uninfected and through
day 21 of infection) to visualize and phenotype the distribution of
CD69+ T cell subsets in tissues by confocal microscopy as
previously described [33]. In brief, formalin-fixed, paraffin
embedded sections were de-paraffinized and antigens ‘‘unmasked’’
using high temperature antigen retrieval consisting of heating
slides in a steam bath chamber (Black and Decker Flavor Center
Steamer Plus) with 0.01 M citrate buffer, pH 6.0 for 20 min,
cooled, and washed twice in PBS.
Three-color fluorescent immunostaining was also compared on
snap-frozen tissues. Briefly, intestinal tissues were rapidly frozen in
optimum cutting temperature compound (Tissue-TekH O.C.T.
Compound, Sakura Finetek) submersed in dry-ice cooled 2-
methylbutane, and 5 mm sections were fixed with cold acetone,
then incubated with CD4 (1F6) or CD8 (1A5, Novocastra
Laboratories Ltd.) or P28 (3F7, Trinity Biotech). Slides were then
washed with PBS and incubated with Alexa Fluor 568 (red) labeled
secondary antibody (goat anti-mouse IgG1, Invitrogen, Carlsbad,
CA), for 30 min, washed and incubated with appropriately diluted
primary antibodies, CD69 (CH/4, Invitrogen, Carlsbad, CA) and
CD3 (rabbit polyclonal, Dako Inc.), washed, and incubated with
Alexa Fluor 488 (green) labeled goat anti-mouse IgG2a (Invitro-
gen, Carlsbad, CA) and Alexa Fluor 633 labeled anti-rabbit IgG
(H+L), (Invitrogen, Carlsbad, CA) secondary antibody to detect
CD4 or CD8 (red) and CD3 (blue), respectively. Finally, slides
were mounted with fluorescent mounting medium (Dako, Inc.)
and visualized using a confocal microscope. Isotype mouse serum
controls were performed on both frozen and paraffin-embedded
slides and no false positive signals were detected for any of these
markers. To determine the proportion of activated cells infected
with SIV, lymph nodes and intestinal tissues from 3 macaques in
primary infection (day 10) were sectioned and triple labeled as
above for P28, CD3 and CD69, and the total number of SIV
infected T cells (P28+CD3+) and SIV infected activated T cells
(P28+CD69+CD3+) were counted and the proportion of infected
activated T cells was calculated.
Confocal microscopy was performed using a Leica TCS SP2
confocal microscope equipped with three lasers (Leica Micro-
systems, Exton, PA). Individual optical slices represent 0.2 mm,
and 32–62 optical slices were collected at 5126512 pixel
resolution. NIH Image (version 1.62) and Adobe Photoshop
(version 7.0) was used to assign colors to the channels collected.
Statistics
Graphical presentation and statistical analysis of the data were
performed using GraphPad Prism 4.0 (GraphPad Software Inc.,
SanDiego, CA). A Mann Whitney U test was used for comparison
of CD69 expression between CD4+ and CD8+ T cells in tissues of
normal macaques. Comparisons of CD69 expression in tissues
during SIV infection were analyzed by a one-way ANOVA and
Dunnett’s Multiple Comparison Test to compare data from
infected and control macaques (P,0.01). Correlations between
CD69 Expression in SIV Infection
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coefficient of correlation.
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